Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spero Therapeutics
Biotech
Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders
Former Biogen CMO is now an executive partner at healthcare investment firm Sofinnova Investments. Flagship Pioneering snags new senior partner.
Darren Incorvaia
,
Zoey Becker
,
Gabrielle Masson
Aug 9, 2024 8:30am
Fierce 15: Where are they now?
Jul 26, 2024 6:50am
Gene editor Metagenomi adds C-suite execs—Chutes & Ladders
Nov 10, 2023 9:30am
GSK pays $66M to rescue Spero's antibiotic after FDA rejection
Sep 22, 2022 6:00am
Spero lays off 75% of staff, drops UTI drug after FDA meeting
May 3, 2022 10:35am
Spero nets $54M biodefense R&D contract for its lead antibiotic
Jul 16, 2018 3:57pm
